Lattice Biologics is scheduled to launch three new products utilizing its patent-pending matrix-assisted regeneration platform.
Here are three highlights:
1. The new products, MarBrane, MarGraft and MarCell are anticipated to significantly accelerate the company's top line revenue growth.
2. MarBrane and MarGraft are expected to launch in second quarter of 2016. MarCell is expected to launch in the third quarter of 2016.
3. Based in Scottsdale, Ariz., Lattice Biologics develops and manufactures biologic products used in a variety of applications, such as spine surgery, orthopedics and sports medicine, among others.